Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 26157
Event :2nd Annual NASH Summit 2018

Dates :Monday April 23rd, 2018 - Wednesday April 25th, 2018

Location :Revere Hotel Boston Common
200 Stuart Street
02116 Boston, United States

Type :Conference & Seminar - International audience

Accreditation :--


 

Further information

As the industry's most comprehensive NASH forum, the NASH Summit returns with an unrivalled depth and breadth of cutting-edge NASH science from drug discovery through to late stage clinical development.

Across 3 parallel streams of learning, 48 expert speakers including Gilead, Allergan and Novartis will share advances in:

. Validating non-invasive biomarkers to confidently stratify patients and enhance clinical response
. Evaluating the scientific rationale behind combination therapy for more effective treatment
. Conclusively comparing in vitro and in vivo models to better recapitulate human NASH and confidently progress into the clinic

Join 150+ drug developers from 120+ organizations at this focused discussion and networking forum. Address this huge unmet clinical need and gain actionable insights to propel your candidate to therapeutic success.

URLs:
Website: https://go.evvnt.com/169819-0
Brochure: https://go.evvnt.com/169819-1
Booking: https://go.evvnt.com/169819-2

Prices:
Conference Only: USD 2599,
Workshop Only: USD 699

Speakers: Jason Campagna (Intercept Pharmaceuticals), Philip Just Larsen (Sanofi), Jamie Bates (Gilead Sciences), Dean Hurn (Genfit), Edgar Charles (Bristol-Myers Squibb)

Time: 8:00 am to 6:00 pm

Location

Map and directions
Conference address :
Revere Hotel Boston Common
200 Stuart Street
02116 Boston
United States
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama

Details

2nd Annual NASH Summit 2018 Medicine
non-alcoholic steatohepatitis, nash, combinational therapy, preclinical modelling, non-invasive biomarker, late stage clinical development, metabolomic, inflammatory biomarkers
Everyone
-- -- --
English

Other

For more information on 2nd Annual NASH Summit 2018, plsase contactr Hanson Wade

To obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama


Recommend this event